IB
Insider
Isaac Barchas
DirectorIsaac Barchas (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Immunome, Inc. (IMNM). The largest single filing was $8.3M of IMNM (383,200 sh across 2 lots, as filed), executed Dec 22 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$18.3M
shares × price, as filed
Last traded
Aug 12
Filed Aug 12
Median ADV $31.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $18.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
IMNMRecent filings
IMNMSALE
Immunome, Inc.
View filing →
$2.2M83,464 sh across 3 lots
Exec Aug 10
Filed Aug 12 · 5:47 PM ET IMNMSALE Immunome, Inc. View filing → $940K
36,088 sh across 2 lots
Exec Aug 6
Filed Aug 10 · 4:10 PM ET IMNMSALE Immunome, Inc. View filing → $2.4M
100,000 sh across 2 lots
Exec Jul 6
Filed Jul 7 · 7:02 PM ET IMNMSALE Immunome, Inc. View filing → $4.4M
201,050 sh across 3 lots
Exec Jun 30
Filed Jul 2 · 8:31 PM ET IMNMSALE Immunome, Inc. View filing → $8.3M
383,200 sh across 2 lots
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET